After the recent Supreme Court decision to allow medical abortions through telehealth services, attorneys general from Kansas and Missouri have renewed their efforts to restrict access to abortion-inducing drugs. The case in question, Stothert v. Planned Parenthood, involved a lower court ruling that allowed patients to receive the abortion pill mifepristone through the mail without an in-person visit to a healthcare provider. The Supreme Court’s decision to not intervene in this ruling has prompted backlash from anti-abortion advocates, who argue that the decision makes it easier for women to obtain abortions without proper medical oversight.
In response to this ruling, Kansas Attorney General Derek Schmidt and Missouri Attorney General Eric Schmitt have come together to push for stricter regulations on the distribution of abortion-inducing drugs. They argue that allowing these drugs to be prescribed and administered without proper medical supervision puts women’s health at risk and undermines state laws that regulate abortion services. Schmidt and Schmitt have called on the FDA to reconsider its guidelines on mifepristone and prevent its distribution through telehealth services.
The attorneys general’s efforts have been met with support from pro-life groups, who believe that the Supreme Court’s decision sets a dangerous precedent for the future of abortion regulations. On the other hand, reproductive rights advocates argue that restricting access to abortion-inducing drugs only serves to limit women’s healthcare options and infringes on their reproductive rights. The debate over abortion access continues to be a contentious issue in both Kansas and Missouri, with both sides of the argument vowing to fight for their respective beliefs.
Source
Photo credit news.google.com